首页> 美国卫生研究院文献>other >How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis
【2h】

How should individuals with a false-positive fecal occult blood test for colorectal cancer be managed? A decision analysis

机译:是否应该如何管理具有假阳性粪便血液测试的个体进行管理?决策分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Several industrialized nations recommend fecal occult blood testing (FOBT) to screen for colorectal cancer (CRC), but corresponding screening guidelines do not specify how individuals with a prior false positive FOBT result (fpFOBT) should be managed in terms of subsequent CRC screening. Accordingly, we conducted a decision analysis to compare different strategies for managing such individuals.We used a previously-developed CRC microsimulation model, SimCRC, to calculate life-years and the lifetime number of colonoscopies (as a measure of required resources) for a cohort of 50-year-olds to whom FOBT-based CRC screening is offered annually from age 50 to 75. We compared three management strategies for individuals with a prior fpFOBT: 1) resume screening in 10 years with 10-yearly colonoscopy (SwitchCol_long); 2) resume screening in 1 year with annual FOBT (ContinueFOBT_Short); and 3) resume screening in 10 years (i.e., the recommended interval following a negative colonscopy) with annual FOBT (ContinueFOBT_long). We performed sensitivity analyses on various parameters and assumptions.When using different management strategies for individuals with a prior fpFOBT the variation in the number of life-years gained relative to no screening was less than 2%, while the variation in the lifetime number of colonoscopies was 23% (percentages are calculated as the maximum difference across strategies divided by the lowest number across strategies). The ContinueFOBT_long strategy showed the lowest lifetime number of colonoscopies per life-year gained even when key assumptions were varied.In conclusion, the ContinueFOBT_long strategy was advantageous regarding both clinical benefit and required resources. Specifying an appropriate management strategy for individuals with a prior fpFOBT may substantially reduce required resources within a FOBT-based CRC screening program without limiting its effectiveness.
机译:若干工业化国家建议粪便潜血检测(FOBT)对结肠直肠癌(CRC)进行筛选,但相应的筛查指南未指定应如何在随后的CRC筛查方面进行以前的误报阳性FOBT结果(FPFOBT)。因此,我们进行了决策分析,以比较管理此类个人的不同策略。我们使用了先前开发的CRC微疗模型,SIMCRC,计算了队列的寿命年份和结肠镜阶段的终身数量(作为所需资源的衡量标准)从50岁到75岁的基于FOBT的CRC筛查提供了50岁的CRC筛选。我们将三个患有先前FPFOBT的人的管理策略与10年(SwitchCol_Long)的10年内恢复筛查; 2)随着年费(ContinueFobt_short)的1年内恢复筛选; 3)随着年费(ContinueFobt_long)的10年内恢复筛选(即,在负殖民复制之后的推荐间隔)。我们对各种参数和假设进行了敏感性分析。当使用先前的FPFOBT的个体的不同管理策略时,相对于没有筛查获得的生命年数的变化小于2%,而结肠镜检查的寿命次数的变化是23%(百分比计算为跨策略的最大频率的最大差异)。即使在各种各样的假设各不相同的时候,ContinueFobt_long战略表明,即使在各种各样的假设变化时,也会获得的每年寿命最低的结肠镜次数。在结论中,ContinueFobt_Long战略有助于临床利益和所需资源。为先前FPFOBT指定适当的管理策略可能在不限制其有效性的基于FOBT的CRC筛选计划中大大减少所需资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号